Clinical Trial

Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare the safety, pharmacokinetics, and pharmacodynamic effects of aspirin administered intravenously with aspirin administered orally.
Protocol Amendment History 3 changes
critical Trial status changed: Enrolling by Invitation → Completed 2026-06-13
notable Primary completion moved earlier: 2026-03-31 -> 2025-07-07 2026-06-13
minor Completion moved earlier: 2026-03-31 -> 2025-12-12 2026-06-13
Trial Details
NCT Number NCT07323680
Lead Sponsor Rhoshan Pharmaceuticals Inc
Conditions Healthy
Enrollment 40 participants
Start Date 2025-06-15
Primary Completion 2025-07-07 (estimated)
Study Completion 2025-12-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-12